Project Number 5U01AG042791-02 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Category G. Consortia and Public Private Partnerships 2. Public Private Partnership Researcher and Organization Principal Investigator Bateman, Randall Principal Investigator First Name Randall Principal Investigator Last Name Bateman Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PA-11-260: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $1,500,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Biomarkers Project Related Resources Clinical Trial Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
